Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide

Catherine Klersy, Gian Vico Melzi d'Eril, Alessandra Barassi, Giovanni Palladini, Mario Comelli, Remigio Moratti, Riccardo Albertini, Giampaolo Merlini

Research output: Contribution to journalArticle

Abstract

Background: Serial measurement of NT-proBNP is performed routinely in the monitoring and assessment of the effectiveness of therapy in patients being treated for chronic heart failure (CHF). Intra-individual changes in NT-proBNP levels over time are compared typically to a reference change value (RCV) determined using either a standard [i.e., nested analysis of variance (nANOVA)] or a lognormal approach. The RCV defines the minimum percent change in serial analyte values that exceeds the percent change expected due to biological variation alone. Currently, there is no consensus on which approach (nANOVA or lognormal) to determining RCV is better. Aims: Based on these considerations, we aimed to illustrate the impact of data transformation on the calculation of the biological variation of NT-proBNP and discuss the utility of logarithmic transformation in monitoring patients with heart failure. Methods: 15 healthy subjects were enrolled after informed consent; 5 blood specimens were collected twice a week. Nested ANOVA from replicate analyses was applied to obtain components of biological variation, on the raw data and after data transformation. Results: NT-proBNP distribution being highly skewed required data transformation. Natural log transformation yielded normalization. An example demonstrates that for untransformed values the RCV was overestimated for low concentrations of NT-proBNP and underestimated for higher concentrations. Conclusions: Log-transformed data are often used in the establishment of reference intervals for evaluating laboratory tests results in clinical practice, especially when the reference interval data are not Gaussian distributed. As log-normal approach is the best approach to determining RCV values we encourage its use assessing the clinical utility of NT-proBNP serial testing. We propose that the log-normal approach becomes the standard approach to determining RCV and replaces the use of nANOVA.

Original languageEnglish
Pages (from-to)544-547
Number of pages4
JournalClinica Chimica Acta
Volume413
Issue number5-6
DOIs
Publication statusPublished - Mar 22 2012

Fingerprint

Brain Natriuretic Peptide
Reference Values
Analysis of variance (ANOVA)
Analysis of Variance
Heart Failure
Patient monitoring
Physiologic Monitoring
Informed Consent
pro-brain natriuretic peptide (1-76)
Healthy Volunteers
Blood
Monitoring
Testing

Keywords

  • Biological variability
  • Monitoring
  • Nested ANOVA
  • Normalizing transformation
  • NT-proBNP
  • Reference change value

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide. / Klersy, Catherine; d'Eril, Gian Vico Melzi; Barassi, Alessandra; Palladini, Giovanni; Comelli, Mario; Moratti, Remigio; Albertini, Riccardo; Merlini, Giampaolo.

In: Clinica Chimica Acta, Vol. 413, No. 5-6, 22.03.2012, p. 544-547.

Research output: Contribution to journalArticle

@article{914d84d0d7504ef8b8d691f6f52559a2,
title = "Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide",
abstract = "Background: Serial measurement of NT-proBNP is performed routinely in the monitoring and assessment of the effectiveness of therapy in patients being treated for chronic heart failure (CHF). Intra-individual changes in NT-proBNP levels over time are compared typically to a reference change value (RCV) determined using either a standard [i.e., nested analysis of variance (nANOVA)] or a lognormal approach. The RCV defines the minimum percent change in serial analyte values that exceeds the percent change expected due to biological variation alone. Currently, there is no consensus on which approach (nANOVA or lognormal) to determining RCV is better. Aims: Based on these considerations, we aimed to illustrate the impact of data transformation on the calculation of the biological variation of NT-proBNP and discuss the utility of logarithmic transformation in monitoring patients with heart failure. Methods: 15 healthy subjects were enrolled after informed consent; 5 blood specimens were collected twice a week. Nested ANOVA from replicate analyses was applied to obtain components of biological variation, on the raw data and after data transformation. Results: NT-proBNP distribution being highly skewed required data transformation. Natural log transformation yielded normalization. An example demonstrates that for untransformed values the RCV was overestimated for low concentrations of NT-proBNP and underestimated for higher concentrations. Conclusions: Log-transformed data are often used in the establishment of reference intervals for evaluating laboratory tests results in clinical practice, especially when the reference interval data are not Gaussian distributed. As log-normal approach is the best approach to determining RCV values we encourage its use assessing the clinical utility of NT-proBNP serial testing. We propose that the log-normal approach becomes the standard approach to determining RCV and replaces the use of nANOVA.",
keywords = "Biological variability, Monitoring, Nested ANOVA, Normalizing transformation, NT-proBNP, Reference change value",
author = "Catherine Klersy and d'Eril, {Gian Vico Melzi} and Alessandra Barassi and Giovanni Palladini and Mario Comelli and Remigio Moratti and Riccardo Albertini and Giampaolo Merlini",
year = "2012",
month = "3",
day = "22",
doi = "10.1016/j.cca.2011.11.012",
language = "English",
volume = "413",
pages = "544--547",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "5-6",

}

TY - JOUR

T1 - Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide

AU - Klersy, Catherine

AU - d'Eril, Gian Vico Melzi

AU - Barassi, Alessandra

AU - Palladini, Giovanni

AU - Comelli, Mario

AU - Moratti, Remigio

AU - Albertini, Riccardo

AU - Merlini, Giampaolo

PY - 2012/3/22

Y1 - 2012/3/22

N2 - Background: Serial measurement of NT-proBNP is performed routinely in the monitoring and assessment of the effectiveness of therapy in patients being treated for chronic heart failure (CHF). Intra-individual changes in NT-proBNP levels over time are compared typically to a reference change value (RCV) determined using either a standard [i.e., nested analysis of variance (nANOVA)] or a lognormal approach. The RCV defines the minimum percent change in serial analyte values that exceeds the percent change expected due to biological variation alone. Currently, there is no consensus on which approach (nANOVA or lognormal) to determining RCV is better. Aims: Based on these considerations, we aimed to illustrate the impact of data transformation on the calculation of the biological variation of NT-proBNP and discuss the utility of logarithmic transformation in monitoring patients with heart failure. Methods: 15 healthy subjects were enrolled after informed consent; 5 blood specimens were collected twice a week. Nested ANOVA from replicate analyses was applied to obtain components of biological variation, on the raw data and after data transformation. Results: NT-proBNP distribution being highly skewed required data transformation. Natural log transformation yielded normalization. An example demonstrates that for untransformed values the RCV was overestimated for low concentrations of NT-proBNP and underestimated for higher concentrations. Conclusions: Log-transformed data are often used in the establishment of reference intervals for evaluating laboratory tests results in clinical practice, especially when the reference interval data are not Gaussian distributed. As log-normal approach is the best approach to determining RCV values we encourage its use assessing the clinical utility of NT-proBNP serial testing. We propose that the log-normal approach becomes the standard approach to determining RCV and replaces the use of nANOVA.

AB - Background: Serial measurement of NT-proBNP is performed routinely in the monitoring and assessment of the effectiveness of therapy in patients being treated for chronic heart failure (CHF). Intra-individual changes in NT-proBNP levels over time are compared typically to a reference change value (RCV) determined using either a standard [i.e., nested analysis of variance (nANOVA)] or a lognormal approach. The RCV defines the minimum percent change in serial analyte values that exceeds the percent change expected due to biological variation alone. Currently, there is no consensus on which approach (nANOVA or lognormal) to determining RCV is better. Aims: Based on these considerations, we aimed to illustrate the impact of data transformation on the calculation of the biological variation of NT-proBNP and discuss the utility of logarithmic transformation in monitoring patients with heart failure. Methods: 15 healthy subjects were enrolled after informed consent; 5 blood specimens were collected twice a week. Nested ANOVA from replicate analyses was applied to obtain components of biological variation, on the raw data and after data transformation. Results: NT-proBNP distribution being highly skewed required data transformation. Natural log transformation yielded normalization. An example demonstrates that for untransformed values the RCV was overestimated for low concentrations of NT-proBNP and underestimated for higher concentrations. Conclusions: Log-transformed data are often used in the establishment of reference intervals for evaluating laboratory tests results in clinical practice, especially when the reference interval data are not Gaussian distributed. As log-normal approach is the best approach to determining RCV values we encourage its use assessing the clinical utility of NT-proBNP serial testing. We propose that the log-normal approach becomes the standard approach to determining RCV and replaces the use of nANOVA.

KW - Biological variability

KW - Monitoring

KW - Nested ANOVA

KW - Normalizing transformation

KW - NT-proBNP

KW - Reference change value

UR - http://www.scopus.com/inward/record.url?scp=84856212591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856212591&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2011.11.012

DO - 10.1016/j.cca.2011.11.012

M3 - Article

C2 - 22155398

AN - SCOPUS:84856212591

VL - 413

SP - 544

EP - 547

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 5-6

ER -